Crossmark

Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer

Crossref DOI link: https://doi.org/10.1007/s10549-019-05258-0

Published Online: 2019-05-03

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cohen, Evan N. https://orcid.org/0000-0003-4192-9644
Fouad, Tamer M.

Lee, Bang-Ning

Arun, Banu K.

Liu, Diane

Tin, Sanda

Gutierrez Barrera, Angelica M.

Miura, Toshihide

Kiyokawa, Iwao

Yamashita, Jun

Alvarez, Ricardo H.

Valero, Vicente

Woodward, Wendy A.

Shen, Yu

Ueno, Naoto T.

Cristofanilli, Massimo

Reuben, James M.
License Information

Text and Data Mining valid from 2019-05-03
More Information

Article History

Received: 31 October 2018

Accepted: 26 April 2019

First Online: 3 May 2019

Compliance with ethical standards

:

: MC has received research Grants from Nittobi Medical, Co. TM, IK and JK are employed by Nittobi Medical, Co. All other authors declare no conflicts of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The project was approved by the Institutional Review Board of The University of Texas MD Anderson Cancer Center.